InsiderClue
← All stocks

LIGAND PHARMACEUTICALS INC

LGND Net selling
CIK 0000886163 #1265 in the set updated 17 Sep 2026
Bought (120 mo)
$3.76M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$195.47M
$2.43M on a plan · $129.99M straight out of an exercise
Sold at will
$63.05M
80 of 261 sales
Net
−$191.71M
−$59.29M against sales at will

By person

17 insiders · 356 transactions
78.4×

Todd C. Davis holds 78.4 times base salary in stock. $56.86M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Todd C. Davis last reported holding, valued at $285.00, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
HIGGINS JOHN L
Director
$854.26K (4)
$55.17M (25) scheduled
−$54.31M
417,695
2.10%
$119.04M
+198.8%
Aryeh Jason
Director
$744.81K (12)
$25.42M (20)
−$24.68M
154,174
0.7734%
$43.94M
−49.6%
FOEHR MATTHEW W
Former Executive Officer
$206.91K (1)
$23.77M (14) scheduled
−$23.56M
162,187
0.8136%
$46.22M
+95.3%
Espinoza Octavio
Chief Financial Officer
$156.09K (2)
$15.27M (25) scheduled
−$15.12M
27,696
0.1389%
$7.89M
+124.8%
Berkman Charles S
Former Executive Officer
—
$12.57M (5)
−$12.57M
23,825
0.1195%
$6.79M
−37.2%
Korenberg Matthew E
President & COO
$43.09K (1)
$12.57M (15) scheduled
−$12.53M
50,777
0.2547%
$14.47M
+233.4%
Reardon Andrew
CLO & Secretary
—
$10.20M (61) scheduled
−$10.20M
36,514
0.1832%
$10.41M
+203.5%
Patel Sunil
Former Director
$178.50K (2)
$10.15M (1) scheduled
−$9.97M
28,820
0.1446%
$8.21M
−25.4%
Sabba Stephen L
Director
—
$6.76M (11) scheduled
−$6.76M
33,629
0.1687%
$9.58M
+20.3%
LAMATTINA JOHN L
Director
—
$6.25M (13) scheduled
−$6.25M
26,969
0.1353%
$7.69M
+28.4%
KOZARICH JOHN W
Director
—
$5.34M (58)
−$5.34M
42,622
0.2138%
$12.15M
+6.3%
Davis Todd C
Chief Executive Officer
$1.58M (6)
$6.49M (6)
−$4.92M
199,513
1.00%
$56.86M
+250.5%
Haas Jason
Director
—
$3.74M (3) scheduled
−$3.74M
3,981
0.0200%
$1.13M
+217.7%
Gray Nancy Ryan
Director
—
$1.43M (3) scheduled
−$1.43M
8,930
0.0448%
$2.55M
+1,142%
Zimmermann Martine
Director
—
$342.00K (1)
−$342.00K
3,897
0.0195%
$1.11M
—
Boyce Sarah
Former Director
—
—
—
2,892
0.0145%
$824.22K
—
Cochran Jennifer R.
Former Director
—
—
—
1,161
0.0058%
$330.89K
—

Individual transactions

51
Insider
Date
Role
Action
Shares
Price
Amount
Reardon Andrew
3 Sep 2026
CLO & Secretary
Sold on a plan
400
$288.98
$115.59K
Reardon Andrew
3 Sep 2026
CLO & Secretary
Sold on a plan
385
$287.53
$110.70K
Reardon Andrew
3 Sep 2026
CLO & Secretary
Sold on a plan
2,115
$286.36
$605.65K
Reardon Andrew
3 Sep 2026
CLO & Secretary
Sold on a plan
1,800
$285.17
$513.30K
Reardon Andrew
3 Sep 2026
CLO & Secretary
Sold on a plan
300
$283.99
$85.20K
KOZARICH JOHN W
1 May 2026
Director
Sold on a plan
116
$234.09
$27.15K
KOZARICH JOHN W
1 May 2026
Director
Sold on a plan
105
$232.57
$24.42K
KOZARICH JOHN W
1 May 2026
Director
Sold on a plan
165
$231.87
$38.26K
KOZARICH JOHN W
1 May 2026
Director
Sold on a plan
1
$229.87
$229.87
KOZARICH JOHN W
1 May 2026
Director
Sold on a plan
80
$227.37
$18.19K
KOZARICH JOHN W
1 Apr 2026
Director
Sold on a plan
159
$204.26
$32.48K
KOZARICH JOHN W
1 Apr 2026
Director
Sold on a plan
43
$202.91
$8.73K
KOZARICH JOHN W
1 Apr 2026
Director
Sold on a plan
79
$202.42
$15.99K
KOZARICH JOHN W
1 Apr 2026
Director
Sold on a plan
40
$201.24
$8.05K
KOZARICH JOHN W
1 Apr 2026
Director
Sold on a plan
146
$199.97
$29.20K
KOZARICH JOHN W
2 Mar 2026
Director
Sold on a plan
42
$203.57
$8.55K
KOZARICH JOHN W
2 Mar 2026
Director
Sold on a plan
50
$202.54
$10.13K
KOZARICH JOHN W
2 Mar 2026
Director
Sold on a plan
83
$201.65
$16.74K
KOZARICH JOHN W
2 Mar 2026
Director
Sold on a plan
41
$200.40
$8.22K
KOZARICH JOHN W
2 Mar 2026
Director
Sold on a plan
204
$199.69
$40.74K
KOZARICH JOHN W
2 Mar 2026
Director
Sold on a plan
47
$197.14
$9.27K
KOZARICH JOHN W
2 Feb 2026
Director
Sold on a plan
23
$197.20
$4.54K
KOZARICH JOHN W
2 Feb 2026
Director
Sold on a plan
381
$196.36
$74.81K
KOZARICH JOHN W
2 Feb 2026
Director
Sold on a plan
23
$195.61
$4.50K
KOZARICH JOHN W
2 Feb 2026
Director
Sold on a plan
1
$192.18
$192.18
KOZARICH JOHN W
2 Feb 2026
Director
Sold on a plan
39
$191.00
$7.45K
KOZARICH JOHN W
2 Jan 2026
Director
Sold on a plan
46
$192.40
$8.85K
KOZARICH JOHN W
2 Jan 2026
Director
Sold on a plan
207
$190.27
$39.39K
KOZARICH JOHN W
2 Jan 2026
Director
Sold on a plan
102
$188.96
$19.27K
KOZARICH JOHN W
2 Jan 2026
Director
Sold on a plan
91
$187.95
$17.10K
KOZARICH JOHN W
2 Jan 2026
Director
Sold on a plan
21
$186.59
$3.92K
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
30
$200.02
$6.00K
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
23
$199.22
$4.58K
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
92
$197.72
$18.19K
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
4
$196.35
$785.38
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
47
$195.80
$9.20K
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
179
$194.76
$34.86K
KOZARICH JOHN W
1 Dec 2025
Director
Sold on a plan
92
$193.86
$17.83K
KOZARICH JOHN W
3 Nov 2025
Director
Sold on a plan
127
$192.38
$24.43K
KOZARICH JOHN W
3 Nov 2025
Director
Sold on a plan
207
$191.25
$39.59K
KOZARICH JOHN W
3 Nov 2025
Director
Sold on a plan
49
$190.26
$9.32K
KOZARICH JOHN W
3 Nov 2025
Director
Sold on a plan
84
$189.00
$15.88K
KOZARICH JOHN W
1 Oct 2025
Director
Sold on a plan
92
$181.18
$16.67K
KOZARICH JOHN W
1 Oct 2025
Director
Sold on a plan
155
$180.01
$27.90K
KOZARICH JOHN W
1 Oct 2025
Director
Sold on a plan
196
$178.41
$34.97K
KOZARICH JOHN W
1 Oct 2025
Director
Sold on a plan
24
$177.60
$4.26K
KOZARICH JOHN W
2 Sep 2025
Director
Sold on a plan
85
$164.25
$13.96K
KOZARICH JOHN W
2 Sep 2025
Director
Sold on a plan
115
$162.52
$18.69K
KOZARICH JOHN W
2 Sep 2025
Director
Sold on a plan
267
$161.51
$43.12K
KOZARICH JOHN W
1 Aug 2025
Director
Sold on a plan
467
$131.88
$61.59K
KOZARICH JOHN W
10 Jul 2025
Director
Sold on a plan
934
$125.00
$116.75K
Showing 250 of 356 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 416
Amendments (4/A) skipped 11
Filings about a different issuer 6
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 130
Sales at will 80
Transactions with no price 0
Shares from compensation/vesting 2,225,995
Sales filed before the plan box existed 46
History held since 6 Sep 2016